Targeted therapy from within

Jul 28, 2009

A group of researchers at Johns Hopkins University has designed nanoparticles that can carry cancer-treating radioisotopes through the body and deliver them selectively to tumors. Today in Anaheim, CA, they will report the latest results of their research, including studies in animal models, at the 51st meeting of the American Association of Physicists in Medicine (AAPM).

The are made with a commercially available product known as "liposomes" -- small chemical spheres made of fatty molecules that can package drugs and other chemicals. Liposomes are a powerful emerging tool in medicine because they can be designed to carry many different drugs and manipulated to control how long they stay in the bloodstream. One type of liposome, Doxil, is already approved by the U.S. Food and Drug Administration (FDA) for delivering Doxorubicin, a chemotherapeutic that is toxic to the heart.

The Hopkins scientists are using liposomes that have been modified with antibodies, a class of immune system proteins that recognize and bind to many different microscopic targets -- bacteria, viruses, other proteins, and human cells. Some antibodies specifically bind to , and by attaching these cancer-specific antibodies to the liposomes, the scientists have created "immunoliposomes," which will wend their way through the bloodstream and seek out tumors inside the body. When they come into contact with their target cells, they deliver their payload into the cells.

"It's a promising approach to solving the problem of how to deliver more of a therapeutic to cancer cells," says George Sgouros, a radiology professor at Johns Hopkins who led the research.

Similar studies by other groups of researchers have already demonstrated how immunoliposomes could be packaged with tiny radioactive tracers used for imaging tumors. What Sgouros and his colleagues have done is figure out how to reproducibly package much more powerful radioisotopes, called alpha-particle emitters that have the ability to kill cancer cells without damaging nearby normal cells, and they have tested how effectively they can treat mice with a very aggressive type of metastatic breast cancer.

Early results show that they can pack a relatively large dose of radionuclides into the liposomes and substantially extend the life of treated mice.

"This treatment is much less toxic than chemotherapy because it is targeted to tumor cells rather than to all rapidly dividing cells " says Sgouros. "Nanoparticles designed to deliver these powerful isotopes have a great potential in cancer therapy, particularly for metastatic disease."

Source: American Institute of Physics

Explore further: Experts cautious over Google nanoparticle project

add to favorites email to friend print save as pdf

Related Stories

Researchers find molecule that targets brain tumors

Dec 29, 2008

UC Davis Cancer Center researchers report today the discovery of a molecule that targets glioblastoma, a highly deadly form of cancer. The finding, which is published in the January 2009 issue of the European Journal of Nu ...

Targeted Nanoparticles Destroy Prostate Tumors

Apr 25, 2006

Biodegradable polymer nanoparticles, linked to a protein-binding nucleic acid known as an aptamer and loaded with the anticancer agent docetaxel, can target and kill prostate tumors growing in mice. Using this targeted nanoparticle ...

Scientists can predict nano drug outcome

Feb 05, 2009

Scientists including one from The University of Texas Health Science Center at Houston successfully predicted the outcome of a nano drug on breast tumors in a pre-clinical study. Their research could help determine which ...

Targeted irradiation: A new weapon against HIV?

Nov 07, 2006

Antiretroviral therapy can keep HIV infection in check and delay and ameliorate the symptoms of HIV/AIDS. However, the drugs do not manage to eradicate the virus completely; individuals have to stay on the drugs permanently. ...

Novel approach to detoxifying cancer drugs

Nov 07, 2006

Anticancer drugs are often highly toxic when delivered straight, but "wrapping" them inside larger molecules can lessen the side effects as well as make them more effective, according to a new study by researchers at the ...

Recommended for you

Nanosafety research: The quest for the gold standard

Oct 29, 2014

Empa toxicologist Harald Krug has lambasted his colleagues in the journal Angewandte Chemie. He evaluated several thousand studies on the risks associated with nanoparticles and discovered no end of shortc ...

New nanodevice to improve cancer treatment monitoring

Oct 27, 2014

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten ...

Molecular beacons shine light on how cells 'crawl'

Oct 24, 2014

Adherent cells, the kind that form the architecture of all multi-cellular organisms, are mechanically engineered with precise forces that allow them to move around and stick to things. Proteins called integrin ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.